| Biomarker ID | 973 |
| PMID | 22901185 |
| Year | 2012 |
| Biomarker | Prostate Specific Antigen (PSA) |
| Biomarker Basis | Concentration Based (U/L) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa [Patients: 7.8±3; Controls: 1.9±0.98] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Controls |
| Type of Biomarker | Diagnostic |
| Cohort | 57 patients with Prostate Cancer were selected for the analysis and were divided into three BMI Groups <23, 23-25, >25 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |